Design (Testphase)
Risk & Weakness
Bankruptcy Study: Stacked Warning Signals
122
Findings
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits
The working version of our own analysis of 792 U.S. bankruptcies since 2005. Its core finding: no single warning sign carries a verdict — even the sharpest one is wrong in more than 95 out of 100 cases. Only accumulation matters. With no signal active, 0.18 percent of companies filed for bankruptcy within twelve months; with six active at once, 3.16 percent did. This scanner counts how many of the study's warning signals are burning at the same time and lists companies with at least three. Counted are the filings with the securities regulator over the past twelve months — exchange notice, late annual or quarterly report, change of auditor, non-reliance on previously issued figures, accelerated credit facility, going-concern doubt — plus the balance-sheet signals: Altman Z″ in the distress zone (below 1.1), interest not earned, operating cash flow negative over four quarters, cash lasting less than four quarters, equity wiped out, current liabilities exceeding current assets. At least one regulatory filing must be among them: a purely balance-sheet stack otherwise catches large buyback-heavy corporations that are no bankruptcy candidates at all. Banks and financial services are excluded because their cash flow swings by design. Important: a hit is a cluster of warning signals, not a bankruptcy verdict — four out of five of these companies survive the year. Source: fundamental data.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Altman Z-Score
- A bankruptcy early-warning system developed by Edward Altman: several balance-sheet ratios are combined into one score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. Values from 2.6 up are considered a safe zone, values below 1.1 a distress zone with elevated bankruptcy risk; in between lies a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Going Concern
- The assumption in a company's annual report that it can continue operating. If auditors raise "substantial doubt" about this, it is one of the sharpest warnings there is - the company could run out of cash.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTX Syntec Optics Holdings Inc. | — | -28 % | 82 8/25 | Stage 2 | D 31 | 4 of 9 | 0.3 $ | Electronic Components | – | — | — | Technology | 6.50 $ | +289.2 % | +326.6 % | +262.8 % | −34.3 % | — | 99 | 13 | 12.3 % | 15.1 % | -0.85 | — | 0.0 | 9.1 | — | — | — | 778.0 | — | 18.8 % | -11.0 % | -30.0 % | -4.6 % | — | — | -4.6 % | — | 0.0 % | 0.0 % | 5.1 | 3.5 % | 21.0 % | — |
| KOD Kodiak Sciences Inc | 08/12 | +137 % | 40 4/22 | Stage 2 | E 23 | 2 of 9 | 2.6 $ | Biotechnology | – | — | — | Healthcare | 41.60 $ | +32.5 % | +21.4 % | +532.4 % | −28.7 % | +51.4 % | 98 | 42 | 8.0 % | 7.7 % | 2.20 | — | 0.0 | — | — | — | — | -0.1 | 0.0 % | — | 0.0 % | -208.8 % | -49.1 % | — | 36.6 % | — | — | 0.0 % | 0.0 % | -15.7 | 99.6 % | 26.4 % | 2.8 (6) |
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | 71 6/22 | Stage 3 | D 29 | 4 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.98 $ | +7.6 % | -7.7 % | -50.2 % | −52.5 % | +241.6 % | 97 | 42 | 16.8 % | 20.7 % | 0.78 | — | 2.8 | 483.3 | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -184.8 % | — | — | +730.9 % | — | 0.0 % | 0.0 % | -116.1 | 6.9 % | 10.1 % | — | |
| QMCO Quantum Corporation | — | -32 % | 62 6/25 | Stage 2 | D 42 | 4 of 9 | 0.3 $ | Computer Hardware | Uses AI | — | Technology | 10.60 $ | +114.1 % | +60.8 % | +32.8 % | −30.0 % | +55.7 % | 94 | 42 | 14.0 % | 14.5 % | 2.96 | — | 1.9 | 1.2 | 0.1 | — | 0.77 | 236.9 | — | 36.9 % | -36.1 % | 0.0 % | -6.6 % | -0.04 | — | -12.1 % | — | 0.0 % | 0.0 % | -26.0 | 12.8 % | 5.8 % | 3.0 (2) | |
| CORZ Core Scientific, Inc. | 08/14 | — | 46 5/25 | Stage 2 | D 44 | 4 of 9 | 6.6 $ | Software - Infrastructure | – | — | — | Technology | 20.70 $ | +100.3 % | +66.6 % | +53.0 % | −10.5 % | +79.3 % | 93 | 80 | 6.3 % | 6.5 % | 5.50 | — | 166.7 | 14.9 | 0.0 | — | — | 454.9 | -18.8 % | 32.1 % | 0.0 % | 0.0 % | -2.4 % | -1.57 | -42.5 % | -37.5 % | — | 0.0 % | 0.0 % | -5.1 | 124.5 % | 22.6 % | 4.7 (16) |
| KOPN Kopin Corporation | 08/11 | +29 % | 20 3/25 | Stage 2 | C 51 | 4 of 9 | 0.7 $ | Electronic Components | – | — | — | Technology | 3.50 $ | +72.9 % | +76.3 % | +96.7 % | −42.7 % | +117.9 % | 93 | 42 | 9.7 % | 10.7 % | 3.47 | 352.8 | 33.0 | 19.1 | 10.7 | — | 8.75 | 123.4 | — | 18.5 % | 5.0 % | 4.4 % | -12.7 % | 0.02 | — | -23.6 % | — | 0.0 % | 0.0 % | -4.9 | 53.5 % | 15.5 % | 5.0 (3) |
| REPL Replimune Group Inc | 07/02 | -31 % | 55 5/22 | Stage 3 | D 32 | 1 of 9 | 0.9 $ | Biotechnology | Neutral | — | Healthcare | 11.20 $ | +17.5 % | -40.2 % | +59.3 % | −15.9 % | +7.1 % | 92 | 42 | 9.2 % | 10.0 % | 0.87 | — | 0.0 | 615.3 | 4.6 | — | — | -0.2 | — | — | 0.0 % | -90.9 % | -45.0 % | 0.36 | — | — | — | 0.0 % | 0.0 % | -8.4 | 96.9 % | 49.9 % | 4.4 (8) | |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | 56 5/22 | Stage 1 | D 29 | 4 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 4.50 $ | +11.6 % | +0.8 % | +85.3 % | −60.2 % | +169.2 % | 91 | 42 | 11.0 % | 10.5 % | 1.27 | — | 0.0 | 31.3 | — | — | — | -3.5 | — | -215.2 % | 0.0 % | -3,439.4 % | -25.3 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -52.2 | 10.5 % | 1.9 % | — |
| SPIR Spire Global Inc | 08/12 | +124 % | 85 10/29 | Stage 2 | D 40 | 4 of 9 | 0.5 $ | Specialty Business Services | Sells AI | — | — | Industrials | 11.50 $ | +132.5 % | +114.7 % | +14.3 % | −38.3 % | +81.5 % | 90 | 42 | 9.1 % | 11.1 % | 2.52 | 7.4 | 0.0 | 6.7 | 5.2 | — | — | 5.9 | — | 42.3 % | 77.1 % | 101.2 % | -27.2 % | 0.13 | — | -35.2 % | — | 0.0 % | 0.0 % | -8.1 | 39.9 % | 11.8 % | 4.6 (5) |
| KPTI Karyopharm Therapeutics Inc | 08/10 | -23 % | 94 9/22 | Stage 2 | D 38 | 4 of 9 | 0.0 $ | Biotechnology | Uses AI | — | — | Healthcare | 1.90 $ | +31.1 % | +35.0 % | -49.6 % | −13.9 % | +42.7 % | 89 | 42 | 7.7 % | 8.7 % | 0.81 | — | 0.0 | 0.3 | 2.4 | — | — | -1.9 | — | 13.5 % | -129.0 % | -891.1 % | -40.6 % | -0.87 | — | +0.6 % | — | 0.0 % | 0.0 % | -48.8 | 83.7 % | 24.8 % | — |
| ELDN Eledon Pharmaceuticals Inc | 08/13 | +58 % | 82 7/22 | Stage 2 | D 30 | 3 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 3.40 $ | +161.6 % | +147.1 % | +7.3 % | −20.7 % | +146.6 % | 88 | 42 | 10.4 % | 7.4 % | 0.96 | — | 5.4 | — | 6.4 | — | — | 0.8 | — | — | 0.0 % | -72.7 % | -35.1 % | 0.01 | — | -100.0 % | — | 0.0 % | 0.0 % | -0.3 | 59.2 % | 9.7 % | — |
| ECOR Electrocore LLC | 08/05 | +35 % | 70 6/22 | Stage 2 | C 45 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 6.10 $ | +86.2 % | +66.4 % | -12.1 % | −31.5 % | +166.6 % | 87 | 42 | 11.0 % | 11.5 % | 0.89 | — | 384.6 | 1.5 | 29.6 | — | — | 0.2 | — | 87.3 % | -44.1 % | -478.7 % | -58.1 % | -1.67 | — | +27.2 % | — | 0.0 % | 0.0 % | -44.7 | 9.2 % | 2.6 % | — |
| ORMP Oramed Pharmaceuticals Inc | 08/13 | +13 % | 71 6/22 | Stage 2 | C 47 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 4.10 $ | +56.9 % | +58.0 % | +103.1 % | −3.7 % | +25.0 % | 87 | 75 | 7.3 % | 6.4 % | 1.20 | 1.5 | 0.0 | — | 0.7 | — | — | 1.6 | — | — | 0.0 % | 58.2 % | -4.3 % | 0.00 | — | -100.0 % | — | 5.4 % | 9.6 % | 13.8 | 37.1 % | 1.7 % | — |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | 82 7/22 | Stage 3 | E 19 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 2.20 $ | +248.7 % | +177.9 % | -12.5 % | −33.6 % | +210.4 % | 86 | 42 | 10.2 % | 9.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -81.9 % | — | — | — | — | 0.0 % | 0.0 % | -16.0 | 15.0 % | 15.8 % | — | |
| CLMT Calumet, Inc. | 08/14 | +35 % | 99 18/23 | Stage 2 | D 44 | 3 of 9 | 3.9 $ | Specialty Chemicals | – | — | — | Basic Materials | 44.20 $ | +65.2 % | +81.8 % | +177.2 % | −11.6 % | -10.4 % | 86 | 95 | 4.7 % | 4.3 % | 0.72 | — | 11.4 | 0.9 | 24.9 | 45.7 | 0.65 | 119.5 | -27.8 % | 6.1 % | -4.5 % | -1,172.2 % | -2.0 % | -2.24 | -37.9 % | -1.3 % | — | 0.0 % | 0.0 % | 0.1 | 53.3 % | 5.3 % | 3.9 (7) |
| ADV Advantage Solutions Inc | 08/06 | -10 % | 97 11/24 | Stage 2 | D 35 | 4 of 9 | 0.5 $ | Advertising Agencies | – | — | — | Communication Services | 39.20 $ | +81.0 % | +112.3 % | +14.6 % | −10.0 % | +8.4 % | 86 | 29 | 9.4 % | 8.9 % | 2.09 | — | 0.0 | 0.1 | 1.1 | 8.4 | — | 24.7 | — | 14.0 % | -6.8 % | -41.5 % | 2.3 % | 3.24 | — | -0.7 % | — | 0.0 % | 0.0 % | 0.4 | 30.8 % | 10.2 % | 3.7 (3) |
| BZFD BuzzFeed Inc | 08/06 | -20 % | 75 7/24 | Stage 3 | D 25 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 1.20 $ | +64.5 % | -12.4 % | -45.2 % | −50.0 % | -25.4 % | 86 | 13 | 10.5 % | 12.3 % | 3.77 | — | 172.4 | 0.5 | — | — | — | -7.7 | — | 40.3 % | -33.3 % | -90.2 % | -5.3 % | — | — | -2.4 % | — | 0.0 % | 0.0 % | -12.8 | 10.0 % | 3.2 % | — |
| ATRA Atara Biotherapeutics Inc | 08/10 | -29 % | 81 7/22 | Stage 3 | D 36 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 8.40 $ | -38.3 % | -67.1 % | -27.3 % | −46.6 % | +33.7 % | 85 | 42 | 8.3 % | 8.3 % | 0.09 | — | 232.6 | 3.3 | 13.3 | — | — | 2.2 | — | 70.1 % | -40.9 % | -2,014.9 % | -3.8 % | -0.27 | — | -6.3 % | — | 0.0 % | 0.0 % | -327.5 | 52.5 % | 7.8 % | — |
| XRX Xerox Corp | 07/30 | -24 % | 60 7/29 | Stage 3 | D 37 | 4 of 9 | 0.4 $ | Business Equipment & Supplies | Sells AI | — | Industrials | 3.00 $ | +35.1 % | +31.2 % | -23.9 % | −52.7 % | +7.5 % | 83 | 64 | 7.0 % | 9.3 % | 2.44 | — | 2.6 | 0.1 | — | 1.6 | 0.20 | 12.2 | — | 30.8 % | -11.9 % | -115.4 % | 1.2 % | — | — | +12.9 % | — | 3.4 % | 3.3 % | 4.3 | 69.9 % | 32.7 % | 2.8 (5) | |
| ACHV Achieve Life Sciences Inc | 08/06 | -5 % | 56 5/22 | Stage 2 | D 26 | 3 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 6.40 $ | +0.8 % | +39.7 % | +146.0 % | −7.5 % | +115.6 % | 79 | 42 | 8.7 % | 8.2 % | 2.22 | — | 35.3 | — | — | — | 17.68 | -2.4 | — | — | 0.0 % | -496.2 % | -108.4 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -29.4 | 61.0 % | 14.4 % | 4.9 (8) |
| PYXS Pyxis Oncology Inc | 08/13 | -7 % | 83 7/22 | Stage 3 | D 42 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 2.70 $ | +82.6 % | +157.7 % | +136.6 % | −59.8 % | +202.7 % | 79 | 42 | 12.6 % | 11.3 % | 1.31 | — | 0.0 | — | 5.3 | — | — | 1.1 | — | 82.8 % | 0.0 % | -121.7 % | -51.9 % | 0.58 | — | -14.2 % | — | 0.0 % | 0.0 % | -24.8 | 33.9 % | 4.3 % | — |
| RDZN Roadzen Inc. | — | -31 % | 74 7/25 | Stage 1 | C 51 | 4 of 9 | 0.1 $ | Software - Application | Sells AI | — | — | Technology | 1.20 $ | -36.1 % | -24.9 % | -8.7 % | −43.4 % | +244.8 % | 79 | 42 | 9.6 % | 8.4 % | 1.20 | — | 0.0 | 2.0 | — | — | — | -4.4 | — | 61.3 % | -40.9 % | 0.0 % | -20.5 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -20.2 | 3.0 % | 1.2 % | — |
| ABOS Acumen Pharmaceuticals Inc | 08/11 | -19 % | 81 7/22 | Stage 2 | E 23 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 2.20 $ | +14.2 % | +28.2 % | +53.6 % | −38.6 % | +234.8 % | 78 | 42 | 7.9 % | 6.8 % | 0.34 | — | 0.0 | — | 1.9 | — | — | -0.6 | — | -31,894.5 % | 0.0 % | -93.2 % | -42.4 % | 0.36 | — | -100.0 % | — | 0.0 % | 0.0 % | -6.5 | 64.2 % | 3.8 % | — |
| LASE Laser Photonics Corporation | 08/21 | -32 % | 90 11/29 | Stage 3 | D 25 | 2 of 9 | 0.1 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 0.98 $ | — | — | -64.8 % | −71.3 % | — | 77 | 3 | 16.3 % | 17.9 % | 2.27 | — | 0.0 | 7.2 | 5.8 | — | — | 28.8 | -303.2 % | -1.2 % | -268.7 % | -727.4 % | -48.1 % | — | -53.3 % | +132.0 % | — | 0.0 % | 0.0 % | -4.9 | 12.0 % | 9.3 % | 5.0 (1) | |
| LTRN Lantern Pharma Inc | 08/12 | -8 % | 57 5/22 | Stage 3 | D 29 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | +26.4 % | +21.9 % | -40.8 % | −36.1 % | +445.0 % | 77 | 42 | 8.4 % | 10.3 % | 2.29 | — | 0.0 | — | 10.1 | — | — | 0.2 | — | — | 0.0 % | -157.4 % | -73.3 % | 0.02 | — | — | — | 0.0 % | 0.0 % | -51.2 | 14.2 % | 10.8 % | — |
| AMC AMC Entertainment Holdings Inc | 08/10 | -32 % | 4 1/24 | Stage 3 | D 41 | 3 of 9 | 2.8 $ | Entertainment | Uses AI | — | Communication Services | 2.80 $ | +33.3 % | +20.8 % | -2.8 % | −47.5 % | -3.0 % | 76 | 42 | 15.0 % | 12.2 % | 2.28 | — | 122.0 | 0.5 | — | 122.3 | 12.22 | 29.4 | — | 18.2 % | -10.6 % | 0.0 % | 2.1 % | — | — | +4.6 % | — | 0.0 % | 0.0 % | -1.5 | 35.8 % | 5.6 % | 2.7 (7) | |
| QBTS D-Wave Quantum Inc. | 08/06 | +479 % | 10 2/25 | Stage 3 | D 42 | 3 of 9 | 6.7 $ | Computer Hardware | – | — | — | Technology | 18.10 $ | -4.3 % | -13.4 % | +5.2 % | −53.1 % | +104.7 % | 75 | 42 | 9.8 % | 11.0 % | 2.10 | — | 0.0 | 536.3 | 6.2 | — | — | -2.1 | -1,914.9 % | 66.3 % | 0.0 % | -55.3 % | -11.8 % | 0.06 | 93.7 % | +178.5 % | — | 0.0 % | 0.0 % | 17.1 | 48.5 % | 20.0 % | 4.5 (6) |
| RCMT RCM Technologies Inc | 08/05 | +18 % | 90 11/29 | Stage 2 | C 52 | 4 of 9 | 0.2 $ | Conglomerates | – | — | — | Industrials | 28.30 $ | +35.9 % | +37.5 % | +17.3 % | −15.5 % | +38.3 % | 75 | 30 | 4.6 % | 5.1 % | 0.29 | 13.7 | 16.2 | 0.6 | 4.5 | 56.9 | 1.36 | 8.9 | — | 27.7 % | 5.0 % | 40.6 % | 11.9 % | 0.78 | — | +14.7 % | — | 0.0 % | 0.0 % | 7.3 | 45.2 % | 4.5 % | — |
| CABA Cabaletta Bio Inc | 08/06 | -25 % | 29 3/22 | Stage 2 | E 23 | 2 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 2.70 $ | +37.9 % | +42.0 % | +76.3 % | −31.0 % | +395.4 % | 73 | 42 | 7.4 % | 7.4 % | 3.26 | — | 0.0 | — | — | — | — | -3.4 | — | — | 0.0 % | -156.0 % | -71.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -10.9 | 63.6 % | 27.8 % | 4.5 (12) |
| TEAD Teads B.V. | 08/06 | -26 % | 75 7/24 | Stage 3 | D 33 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 0.71 $ | +65.5 % | -10.0 % | -72.0 % | −65.2 % | +10.1 % | 72 | 30 | 13.2 % | 12.5 % | 1.65 | — | 0.0 | 0.1 | 1.5 | — | — | 98.7 | — | 33.6 % | -39.1 % | -190.9 % | -1.3 % | 13.00 | — | +46.1 % | — | 0.0 % | 0.0 % | -0.7 | 30.0 % | 11.3 % | — |
| SCLX Scilex Holding Company | 08/12 | -32 % | 58 5/22 | Stage 3 | D 40 | 4 of 9 | 0.0 $ | Drug Manufacturers - General | Neutral | — | — | Healthcare | 6.60 $ | -9.4 % | -9.4 % | -20.2 % | −79.3 % | +6,811.1 % | 72 | 42 | 13.4 % | 12.2 % | 1.73 | — | 2.7 | 1.4 | — | — | — | -2.6 | — | 59.7 % | 0.0 % | 0.0 % | -92.8 % | — | — | -46.5 % | — | 0.0 % | 0.0 % | -26.0 | 13.1 % | 3.7 % | — |
| PR Permian Resources Corporation | 08/05 | +37 % | 53 2/10 | Stage 2 | D 41 | 4 of 9 | 18.3 $ | Oil & Gas E&P | – | — | — | Energy | 21.30 $ | +39.0 % | +35.3 % | +56.5 % | −16.8 % | +17.6 % | 68 | 4 | 3.0 % | 3.2 % | 0.45 | 23.8 | 10.7 | 3.6 | 1.6 | 54.1 | 1.34 | 6.5 | 9.2 % | 73.3 % | 12.8 % | 6.9 % | 5.3 % | 0.33 | 63.0 % | +1.3 % | — | 2.9 % | 54.9 % | 5.5 | 90.6 % | 3.1 % | 4.6 (20) |
| PRKS United Parks & Resorts Inc | 08/06 | -6 % | 43 6/31 | Stage 3 | D 30 | 4 of 9 | 2.1 $ | Leisure | – | — | — | Consumer Cyclical | 44.60 $ | +27.5 % | +31.1 % | -5.7 % | −18.5 % | +3.8 % | 67 | 16 | 3.7 % | 4.7 % | 1.15 | 17.0 | 6.3 | 1.3 | 174.6 | 7.2 | — | 8.7 | -2.8 % | 46.9 % | 9.1 % | 0.0 % | 8.7 % | -4.29 | -21.4 % | -3.6 % | — | 0.0 % | 0.0 % | 4.4 | 141.1 % | 29.4 % | 3.7 (12) |
| BALY Bally's Corp | 08/10 | +0 % | 33 5/31 | Stage 3 | D 40 | 4 of 9 | 0.7 $ | Resorts & Casinos | – | — | — | Consumer Cyclical | 13.90 $ | -12.2 % | -22.6 % | +50.1 % | −30.3 % | -11.9 % | 65 | 99 | 8.2 % | 7.2 % | 2.05 | — | 45.9 | 0.2 | — | — | — | 71.9 | — | 59.3 % | -30.0 % | -54.6 % | 0.1 % | — | — | +8.4 % | — | 0.0 % | 0.0 % | 3.1 | 77.5 % | 9.6 % | 3.0 (5) |
| ZBIO Zenas BioPharma, Inc. | 08/11 | — | 81 7/22 | Stage 4 | D 41 | 2 of 9 | 2.0 $ | Biotechnology | – | — | — | Healthcare | 31.40 $ | -44.4 % | -40.8 % | +100.1 % | −44.7 % | +38.5 % | 57 | 42 | 8.2 % | 7.6 % | — | — | 0.0 | 203.7 | — | — | — | 0.0 | — | — | 0.0 % | -137.1 % | -29.1 % | — | — | +100.0 % | — | 0.0 % | 0.0 % | 2.6 | 90.5 % | 28.7 % | 4.7 (7) |
| BIRD Allbirds Inc | 08/06 | -32 % | 21 4/31 | Stage 3 | E 17 | 3 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 2.20 $ | +24.9 % | -84.6 % | -78.0 % | −82.4 % | +227.1 % | 57 | 42 | 23.0 % | 13.8 % | 2.56 | — | 0.0 | 0.2 | 1.4 | — | — | -0.6 | — | 38.1 % | -53.4 % | -153.7 % | -38.8 % | 2.04 | — | -19.7 % | — | 0.0 % | 0.0 % | -23.1 | 35.4 % | 16.9 % | — |
| KULR KULR Technology Group Inc | 08/13 | -9 % | 20 3/25 | Stage 2 | C 49 | 4 of 9 | 0.1 $ | Electronic Components | – | — | — | Technology | 2.70 $ | +30.4 % | +11.8 % | -51.7 % | −52.9 % | +113.9 % | 56 | 42 | 9.7 % | 11.7 % | 2.26 | — | 128.2 | 6.7 | — | — | — | -6.4 | — | -0.8 % | 0.0 % | -77.3 % | -25.1 % | — | — | +50.6 % | — | 0.0 % | 0.0 % | 2.9 | 22.6 % | 21.2 % | — |
| NB NioCorp Developments Ltd. | 07/10 | -1 % | 37 4/23 | Stage 4 | C 45 | 4 of 9 | 0.7 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 4.30 $ | -7.4 % | -25.1 % | +50.9 % | −63.4 % | +172.6 % | 55 | 42 | 5.6 % | 7.2 % | 0.17 | — | 0.0 | — | 1.4 | — | — | -3.3 | — | — | 0.0 % | -24.5 % | -8.7 % | 0.00 | — | -8.0 % | — | 0.0 % | 0.0 % | 20.0 | 38.1 % | 7.6 % | 4.0 (2) |
| NEXT Nextdecade Corp | 07/30 | -1 % | — | Stage 2 | D 27 | 1 of 9 | 1.7 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 6.70 $ | +27.7 % | +28.2 % | -40.9 % | −40.8 % | +38.1 % | 54 | 50 | 7.0 % | 5.7 % | 1.51 | — | 0.0 | — | 21.7 | — | — | 196.5 | 0.0 % | — | 0.0 % | -18.6 % | -1.2 % | 89.31 | 0.8 % | — | — | 0.0 % | 0.0 % | -0.1 | 45.0 % | 13.1 % | 3.5 (2) | |
| AURA Aura Biosciences Inc | 08/12 | -15 % | 40 4/22 | Stage 2 | D 25 | 1 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 7.00 $ | +28.8 % | +17.0 % | +1.7 % | −28.1 % | +168.6 % | 54 | 42 | 6.5 % | 5.5 % | 0.40 | — | 0.0 | — | 6.9 | — | — | -5.7 | — | — | 0.0 % | -95.6 % | -50.6 % | 0.16 | — | — | — | 0.0 % | 0.0 % | -5.9 | 51.0 % | 5.5 % | 4.6 (7) |
| PDSB PDS Biotechnology Corp | 08/12 | -28 % | 82 7/22 | Stage 2 | D 27 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.69 $ | +18.5 % | +0.6 % | -35.9 % | −44.8 % | +742.7 % | 53 | 42 | 9.6 % | 11.2 % | 1.58 | — | 0.0 | — | 9.7 | — | — | -2.6 | — | — | 0.0 % | -254.1 % | -50.5 % | 4.08 | — | — | — | 0.0 % | 0.0 % | -28.7 | 9.2 % | 2.8 % | — |
| SRI Stoneridge Inc | 08/05 | -20 % | 44 6/31 | Stage 2 | D 25 | 3 of 9 | 0.2 $ | Auto Parts | – | — | — | Consumer Cyclical | 6.90 $ | +18.7 % | +33.7 % | -10.3 % | −27.3 % | +105.4 % | 49 | 90 | 5.2 % | 5.5 % | 1.85 | — | 15.5 | 0.2 | 1.3 | — | 0.26 | 17.6 | — | 19.7 % | -14.1 % | -53.6 % | -1.8 % | 1.04 | — | -5.2 % | — | 0.0 % | 0.0 % | 5.7 | 84.3 % | 1.8 % | — |
| RGNX Regenxbio Inc | 08/06 | -16 % | 15 2/22 | Stage 4 | D 27 | 1 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 9.70 $ | -30.9 % | -18.2 % | +13.9 % | −36.8 % | +150.2 % | 46 | 42 | 13.1 % | 9.4 % | 0.90 | — | 0.0 | 5.6 | — | — | 0.26 | -3.4 | — | -196.6 % | 0.0 % | -196.4 % | -38.5 % | — | — | +104.5 % | — | 0.0 % | 0.0 % | -10.9 | 84.7 % | 18.0 % | 4.4 (12) |
| OSTX OS Therapies Incorporated | 08/17 | — | 82 7/22 | Stage 3 | D 27 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.50 $ | +30.0 % | +47.4 % | -14.6 % | −30.0 % | +422.1 % | 45 | 42 | 8.5 % | 8.3 % | — | — | 1.7 | — | 11.4 | — | — | 0.0 | — | — | 0.0 % | -914.0 % | -366.6 % | -0.12 | — | — | — | 0.0 % | 0.0 % | -78.9 | 6.5 % | 4.9 % | — |
| FSI Flexible Solutions International Inc | 08/13 | +50 % | 76 7/23 | Stage 3 | C 49 | 3 of 9 | 0.1 $ | Specialty Chemicals | – | — | — | Basic Materials | 5.10 $ | -4.2 % | -4.2 % | -5.5 % | −44.4 % | +33.2 % | 44 | 77 | 3.8 % | 3.4 % | 1.65 | 90.8 | 26.0 | 1.6 | 1.8 | — | 7.67 | 15.1 | — | 31.7 % | 2.1 % | 5.6 % | 3.5 % | 0.34 | — | +0.7 % | — | 0.0 % | 0.0 % | 8.7 | 10.4 % | 0.9 % | — |
| SPCE Virgin Galactic Holdings Inc | 08/05 | -32 % | 18 3/29 | Stage 1 | D 40 | 3 of 9 | 0.3 $ | Aerospace & Defense | Neutral | — | Industrials | 2.60 $ | -6.5 % | -12.0 % | -32.9 % | −71.9 % | +42.0 % | 43 | 42 | 11.4 % | 18.9 % | 2.74 | — | 0.0 | 220.0 | — | — | — | -0.1 | — | -6,127.7 % | 0.0 % | -104.5 % | -19.8 % | — | — | -78.1 % | — | 0.0 % | 0.0 % | -10.8 | 15.8 % | 32.4 % | — | |
| FRPH Frp Holdings Ord | 08/05 | -4 % | 8 1/21 | Stage 3 | D 36 | 3 of 9 | 0.4 $ | Real Estate Services | – | — | — | Real Estate | 22.30 $ | +7.7 % | +12.4 % | -15.5 % | −11.7 % | +101.8 % | 41 | 7 | 3.0 % | 2.6 % | 0.51 | 446.0 | 17.4 | 9.7 | 1.0 | 11.9 | 1.12 | 35.3 | — | 63.6 % | 2.8 % | 0.1 % | -0.2 % | 0.48 | — | +2.6 % | — | 0.0 % | 0.0 % | 7.1 | 47.4 % | 2.8 % | — |
| ELUT Elutia Inc. | 08/13 | -20 % | 93 9/22 | Stage 2 | D 32 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.86 $ | +48.7 % | +71.0 % | -57.8 % | −64.1 % | +426.3 % | 41 | 42 | 7.1 % | 8.1 % | 0.85 | — | 0.0 | 2.7 | 1.8 | — | — | -3.3 | — | 56.3 % | 400.2 % | 0.0 % | -26.4 % | 0.52 | — | -49.6 % | — | 0.0 % | 0.0 % | -7.2 | 45.7 % | 0.1 % | — |
| NG NovaGold Resources Inc | — | +19 % | 11 2/23 | Stage 4 | D 29 | 4 of 9 | 2.5 $ | Gold | – | — | — | Basic Materials | 5.80 $ | -22.5 % | -39.5 % | +12.3 % | −57.3 % | +139.8 % | 40 | 42 | 8.2 % | 6.7 % | 2.15 | — | 4.9 | — | — | — | 1.34 | -40.4 | 0.0 % | — | 0.0 % | -52.0 % | -4.4 % | — | 70.3 % | -100.0 % | — | 0.0 % | 0.0 % | -2.2 | 79.3 % | 8.3 % | 4.4 (8) |
| MXCT MaxCyte Inc | 08/05 | -25 % | 89 8/22 | Stage 3 | D 44 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 1.10 $ | -24.2 % | -22.5 % | -49.0 % | −46.4 % | +223.4 % | 40 | 42 | 6.6 % | 7.0 % | 1.66 | — | 0.0 | 3.7 | — | — | — | -11.1 | — | 80.5 % | -121.2 % | -21.3 % | -11.3 % | — | — | -14.5 % | — | 0.0 % | 0.0 % | 7.9 | 68.0 % | 4.0 % | — |
| RICK RCI Hospitality Holdings Inc | 08/10 | -21 % | 12 3/31 | Stage 3 | D 34 | 4 of 9 | 0.2 $ | Restaurants | – | — | — | Consumer Cyclical | 25.10 $ | +13.6 % | +18.5 % | -29.2 % | −34.6 % | +262.2 % | 38 | 93 | 4.0 % | 4.1 % | 0.76 | — | 5.8 | 0.7 | 0.8 | 4.8 | 0.71 | 15.6 | — | 85.1 % | -2.3 % | -2.5 % | 4.0 % | 1.21 | — | -5.5 % | — | 1.2 % | 71.4 % | 4.9 | 48.4 % | 13.9 % | — |
| QS QuantumScape Corporation | 07/22 | +3 % | 32 5/31 | Stage 4 | D 34 | 4 of 9 | 3.3 $ | Auto Parts | Uses AI | — | — | Consumer Cyclical | 5.20 $ | -28.8 % | -32.1 % | -39.3 % | −62.6 % | +28.1 % | 36 | 42 | 7.6 % | 7.9 % | 2.62 | — | 0.0 | — | 2.9 | — | — | -7.2 | 0.0 % | — | 0.0 % | -38.0 % | -24.3 % | 0.06 | 90.3 % | — | — | 0.0 % | 0.0 % | 5.0 | 41.9 % | 20.7 % | 2.7 (9) |
| IMMR Immersion Corporation | 08/07 | +3 % | 47 5/25 | Stage 3 | D 41 | 1 of 9 | 0.3 $ | Software - Application | – | — | — | Technology | 7.60 $ | -1.0 % | +1.6 % | +13.0 % | −18.0 % | +102.1 % | 35 | 11 | 4.7 % | 4.3 % | 1.00 | — | 18.4 | 0.1 | — | 6.0 | 2.21 | 6.7 | — | 21.3 % | -1.0 % | 19.6 % | 5.0 % | — | — | +12.0 % | — | 4.4 % | 23.3 % | 5.8 | 52.0 % | 12.4 % | — |
| SACH Sachem Capital Corp | 08/04 | -19 % | 85 7/21 | Stage 1 | E 21 | 4 of 9 | 0.0 $ | REIT - Mortgage | – | — | — | Real Estate | 0.82 $ | -4.2 % | +0.6 % | -19.2 % | −35.5 % | +27.7 % | 33 | 23 | 3.9 % | 6.9 % | 1.18 | — | 19.0 | 0.7 | — | 12.1 | 0.32 | 10.7 | — | 100.0 % | -4.6 % | -0.4 % | -0.1 % | — | — | -18.2 % | — | 16.8 % | 500.0 % | 4.1 | 19.6 % | 0.3 % | — |
| PRME Prime Medicine, Inc. Common Stock | 08/06 | -26 % | 56 5/22 | Stage 4 | D 34 | 1 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 2.90 $ | -6.6 % | +4.2 % | -21.9 % | −54.2 % | +145.4 % | 32 | 42 | 10.1 % | 9.0 % | 2.27 | — | 0.0 | 136.5 | 7.4 | — | — | -3.1 | — | -3,722.0 % | 0.0 % | -216.1 % | -41.5 % | 1.49 | — | +55.3 % | — | 0.0 % | 0.0 % | -9.0 | 66.6 % | 23.8 % | 4.2 (12) |
| ELWT Elauwit Connection, Inc. Common Stock | 08/13 | — | 94 10/24 | Stage 1 | D 36 | 3 of 9 | 0.1 $ | Telecom Services | – | — | — | Communication Services | 8.20 $ | +18.9 % | +30.7 % | — | −36.8 % | +95.4 % | 31 | 42 | 10.5 % | 10.2 % | — | — | 0.0 | 2.6 | 23.9 | — | — | 0.0 | — | 17.3 % | -28.9 % | 0.0 % | -35.6 % | 0.82 | — | +154.5 % | — | 0.0 % | 0.0 % | -4.6 | 8.6 % | 1.1 % | — |
| GNLX Genelux Corporation Common Stock | 08/06 | -31 % | 41 4/22 | Stage 4 | D 28 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 3.00 $ | -33.0 % | -34.1 % | -13.3 % | −66.0 % | +503.4 % | 28 | 42 | 6.2 % | 5.6 % | 0.57 | — | 0.0 | — | 5.8 | — | — | -327.2 | — | 100.0 % | 0.0 % | -127.3 % | -60.6 % | 0.11 | — | +0.0 % | — | 0.0 % | 0.0 % | -26.5 | 30.7 % | 7.3 % | — |
| SPRU Spruce Power Holding Corp | 08/10 | -20 % | 83 8/25 | Stage 4 | D 31 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 2.00 $ | -46.6 % | -49.9 % | +53.5 % | −61.9 % | +133.5 % | 27 | 42 | 4.6 % | 6.3 % | 1.16 | — | 45.2 | 0.3 | 0.3 | 40.0 | — | 9.9 | — | 67.6 % | -12.2 % | -10.5 % | 1.7 % | 5.76 | — | +36.2 % | — | 0.0 % | 0.0 % | 1.4 | 35.7 % | 4.9 % | — |
| FIP FTAI Infrastructure Inc. | 08/06 | +16 % | 37 5/29 | Stage 4 | D 43 | 4 of 9 | 0.4 $ | Conglomerates | Neutral | — | — | Industrials | 3.70 $ | +1.7 % | -8.6 % | -39.0 % | −38.1 % | +168.6 % | 25 | 42 | 6.2 % | 6.5 % | 1.88 | — | 83.3 | 0.7 | 21.4 | — | — | 51.4 | — | 40.7 % | -78.6 % | -61.1 % | 0.6 % | 3.91 | — | +51.6 % | — | 3.2 % | 0.0 % | 3.1 | 86.4 % | 25.6 % | 4.7 (3) |
| DXLG Destination XL Group Inc | — | -29 % | 52 7/31 | Stage 4 | E 24 | 2 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 0.56 $ | -24.8 % | -29.1 % | -56.9 % | −61.5 % | +92.3 % | 24 | 7 | 8.2 % | 8.1 % | 1.32 | — | 149.3 | 0.1 | 0.3 | — | 1.60 | 344.2 | — | 43.2 % | -9.2 % | -32.8 % | -2.5 % | 2.08 | — | -6.9 % | — | 0.0 % | 0.0 % | 2.9 | 67.3 % | 2.8 % | — |
| ULBI Ultralife Corporation | 08/06 | +10 % | 49 6/29 | Stage 1 | D 37 | 4 of 9 | 0.1 $ | Electrical Equipment & Parts | – | — | — | Industrials | 5.20 $ | +7.7 % | +2.0 % | -34.9 % | −34.6 % | +124.7 % | 24 | 8 | 4.0 % | 6.0 % | 0.78 | — | 15.3 | 0.4 | 0.7 | 13.8 | 3.81 | 149.7 | — | 23.1 % | -4.4 % | -6.2 % | 1.6 % | 0.37 | — | +16.2 % | — | 0.0 % | 0.0 % | 5.9 | 73.8 % | 0.7 % | — |
| VHC VirnetX Holding Corp Common Stock | 08/11 | +11 % | 62 6/25 | Stage 4 | D 31 | 2 of 9 | 0.1 $ | Software - Infrastructure | – | — | — | Technology | 13.00 $ | -26.1 % | -31.3 % | -10.9 % | −59.3 % | -75.6 % | 24 | 42 | 7.9 % | 9.2 % | 2.27 | — | 3.6 | 270.0 | 2.9 | — | 0.24 | 1.7 | — | 100.0 % | 0.0 % | -68.5 % | -33.8 % | — | — | +3,140.0 % | — | 0.0 % | 0.0 % | -22.9 | 13.1 % | 4.3 % | — |
| ESLA Estrella Immunopharma Inc. | — | -32 % | 82 7/22 | Stage 4 | D 30 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.71 $ | -35.9 % | -35.2 % | -15.0 % | −69.8 % | +1,163.2 % | 23 | 42 | 8.2 % | 8.7 % | 0.86 | — | 0.0 | — | 3.1 | — | — | -3.1 | — | — | 0.0 % | -268.5 % | -271.5 % | — | — | — | — | 0.0 % | 0.0 % | -54.7 | 12.2 % | 0.7 % | — |
| FTCI FTC Solar Inc | 08/04 | -30 % | 62 6/25 | Stage 4 | C 53 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 2.80 $ | -52.2 % | -58.7 % | -51.8 % | −64.2 % | +124.8 % | 22 | 42 | 9.6 % | 9.9 % | 1.81 | — | 18.8 | 0.4 | 7.5 | — | — | -0.7 | — | 1.4 % | -44.9 % | -955.8 % | -25.3 % | -3.81 | — | +110.5 % | — | 0.0 % | 0.0 % | -10.6 | 10.1 % | 9.0 % | — |
| DYAI Dyadic International Inc | 08/12 | -20 % | 93 9/22 | Stage 4 | C 50 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -14.3 % | -10.6 % | -0.9 % | −45.0 % | +710.8 % | 21 | 42 | 11.8 % | 9.7 % | 1.15 | — | 6.8 | 13.3 | 31.2 | — | — | -2.9 | — | 26.1 % | -191.5 % | -2,826.9 % | -56.2 % | -12.39 | — | -64.7 % | — | 0.0 % | 0.0 % | -34.1 | 15.0 % | 0.5 % | — |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | 08/13 | — | 17 2/22 | Stage 4 | D 32 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | -6.0 % | -12.0 % | -35.3 % | −60.3 % | +1,160.2 % | 21 | 42 | 6.0 % | 5.5 % | -0.24 | — | 0.0 | — | 17.0 | — | — | 0.0 | — | — | 0.0 % | -384.3 % | -186.9 % | 0.04 | — | — | — | 0.0 % | 0.0 % | -14.4 | 3.3 % | 1.7 % | — |
| BKKT Bakkt Holdings Inc | 08/10 | -30 % | 20 3/25 | Stage 4 | E 19 | 3 of 9 | 0.3 $ | Software - Infrastructure | – | — | — | Technology | 7.20 $ | -11.7 % | -23.3 % | -27.6 % | −84.3 % | +142.7 % | 20 | 42 | 9.7 % | 10.7 % | 5.90 | — | 0.0 | 0.2 | 2.0 | — | — | 0.8 | — | -6.9 % | -8.4 % | -102.0 % | -37.4 % | 0.00 | — | -33.1 % | — | 0.0 % | 0.0 % | -7.7 | 21.4 % | 25.0 % | — |
| TVGN Tevogen Bio Holdings Inc. | 08/18 | -33 % | 58 5/22 | Stage 4 | E 19 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 7.10 $ | -42.5 % | -68.2 % | -85.7 % | −20.7 % | -79.0 % | 20 | 42 | 12.9 % | 16.1 % | 0.22 | — | 0.0 | — | 0.0 | — | — | 18.3 | — | — | 0.0 % | 0.0 % | -294.4 % | -0.31 | — | — | — | 0.0 % | 0.0 % | -129.5 | 3.6 % | 5.3 % | — |
| AZTA Azenta Inc | 08/04 | -16 % | 6 1/22 | Stage 4 | D 38 | 3 of 9 | 1.3 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 28.10 $ | -33.3 % | -26.1 % | -14.0 % | −41.0 % | -1.1 % | 19 | 99 | 4.7 % | 5.0 % | 1.37 | — | 29.1 | 2.2 | 0.8 | 44.8 | 0.53 | 26.5 | — | 44.3 % | -29.1 % | -6.8 % | -0.6 % | 0.04 | — | +3.6 % | — | 0.0 % | 0.0 % | 11.1 | 120.4 % | 20.6 % | 3.4 (7) |
| CMTL Comtech Telecommunications Corp | — | -29 % | 35 4/25 | Stage 1 | D 43 | 4 of 9 | 0.1 $ | Communication Equipment | – | — | — | Technology | 1.70 $ | -54.8 % | -54.1 % | -22.6 % | −67.0 % | +192.7 % | 18 | 95 | 14.2 % | 10.9 % | 1.50 | — | 5.3 | 0.1 | 1.0 | 3.3 | 0.66 | 8.8 | — | 33.0 % | -5.5 % | -9.1 % | 0.4 % | 0.96 | — | -7.6 % | — | 0.0 % | 0.0 % | 4.5 | 54.4 % | 0.8 % | — |
| ARCT Arcturus Therapeutics Holdings Inc | 08/10 | -24 % | 29 3/22 | Stage 4 | D 30 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 5.80 $ | +15.5 % | +4.9 % | -52.8 % | −71.8 % | +202.1 % | 16 | 42 | 5.9 % | 5.8 % | 2.36 | — | 2.3 | 3.6 | 0.9 | — | — | -25.7 | — | -80.7 % | -143.8 % | -37.0 % | -19.1 % | 0.13 | — | -51.4 % | — | 0.0 % | 0.0 % | 2.7 | 80.3 % | 29.4 % | — |
| AHT Ashford Hospitality Trust Inc | 07/29 | -30 % | 75 6/21 | Stage 4 | D 31 | 4 of 9 | 0.0 $ | REIT - Hotel & Motel | Neutral | — | Real Estate | 3.20 $ | -23.9 % | -15.2 % | -49.2 % | −57.5 % | +55.8 % | 16 | 42 | 3.8 % | 3.5 % | 1.69 | — | 10.5 | 0.0 | — | 0.9 | 0.86 | 12.3 | — | 20.8 % | -20.4 % | -2,260.4 % | 1.4 % | — | — | -5.8 % | — | 0.0 % | 0.0 % | -5.8 | 15.9 % | 0.0 % | — | |
| EXOZ eXoZymes, Inc. | 08/11 | — | 82 7/22 | Stage 4 | E 14 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.70 $ | -29.4 % | -32.5 % | -54.0 % | −59.8 % | — | 16 | 42 | 12.9 % | 9.0 % | — | — | 0.0 | — | 28.0 | — | — | 0.0 | — | — | 0.0 % | -185.8 % | -81.6 % | 0.76 | — | — | — | 0.0 % | 0.0 % | -31.3 | 0.7 % | 0.3 % | — |
| INMB INmune Bio Inc | 08/06 | -28 % | 16 2/22 | Stage 4 | D 40 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.80 $ | -9.0 % | -8.5 % | -35.9 % | −87.2 % | +369.8 % | 15 | 42 | 11.0 % | 7.8 % | 0.98 | — | 0.0 | — | — | — | — | -5.3 | — | — | 0.0 % | -168.8 % | -52.6 % | — | — | +257.1 % | — | 0.0 % | 0.0 % | -20.5 | 19.7 % | 15.5 % | — |
| RR Richtech Robotics Inc. Class B Common Stock | 07/01 | — | 37 5/29 | Stage 4 | D 44 | 4 of 9 | 0.3 $ | Specialty Industrial Machinery | – | — | — | Industrials | 1.40 $ | -37.5 % | -45.8 % | -25.3 % | −74.6 % | +111.6 % | 15 | 42 | 7.4 % | 9.5 % | -0.85 | — | 0.0 | 63.7 | 0.9 | — | — | 0.0 | — | 55.8 % | 0.0 % | -10.6 % | -8.1 % | 0.00 | — | +19.0 % | — | 0.0 % | 0.0 % | 45.2 | 40.4 % | 27.4 % | — |
| ATHR Aether Holdings, Inc. | — | — | 81 8/25 | Stage 4 | D 36 | 4 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 3.30 $ | -48.4 % | -22.1 % | -65.4 % | −76.9 % | +131.9 % | 14 | 42 | 15.2 % | 10.7 % | — | — | 0.0 | 35.0 | — | — | — | 0.0 | — | 76.6 % | 0.0 % | -545.1 % | -183.5 % | — | — | -4.1 % | — | 0.0 % | 0.0 % | -10.9 | 1.0 % | 6.7 % | — |
| QSI QuantumSi Inc | 08/04 | -25 % | 17 2/22 | Stage 4 | D 40 | 1 of 9 | 0.2 $ | Medical Devices | – | — | — | Healthcare | 0.71 $ | -20.0 % | -32.1 % | -51.9 % | −72.4 % | +190.7 % | 12 | 42 | 9.5 % | 9.4 % | 3.20 | — | 0.0 | 77.0 | 0.7 | — | — | 0.6 | — | 40.0 % | 0.0 % | -46.4 % | -24.8 % | 0.02 | — | -20.3 % | — | 0.0 % | 0.0 % | 9.5 | 29.9 % | 12.7 % | — |
| ATNM Actinium Pharmaceuticals Inc | 08/14 | -29 % | 70 6/22 | Stage 4 | D 42 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.84 $ | -25.0 % | -37.7 % | -48.7 % | −49.7 % | +426.3 % | 12 | 42 | 5.1 % | 5.7 % | -0.02 | — | 6.8 | 250.0 | 11.4 | — | — | -3.6 | — | 100.0 % | 0.0 % | -167.7 % | -28.0 % | 0.66 | — | -100.0 % | — | 0.0 % | 0.0 % | -24.8 | 20.6 % | 3.0 % | — |
| RNTX Rein Therapeutics Inc | 08/13 | -25 % | 58 5/22 | Stage 4 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.74 $ | -16.5 % | -21.2 % | -36.7 % | −57.1 % | +751.1 % | 12 | 42 | 8.9 % | 8.4 % | 1.35 | — | 0.0 | — | — | — | — | -0.6 | — | — | 0.0 % | -163.4 % | -32.1 % | — | — | — | — | 0.0 % | 0.0 % | -60.0 | 24.6 % | 0.4 % | — |
| TCX Tucows Inc. | 08/06 | -17 % | 73 7/25 | Stage 4 | D 37 | 3 of 9 | 0.2 $ | Software - Infrastructure | – | — | — | Technology | 15.40 $ | -39.0 % | -38.1 % | -10.4 % | −47.0 % | +1,024.5 % | 11 | 84 | 4.6 % | 4.4 % | 0.90 | — | 30.5 | 0.4 | — | — | 1.89 | 20.2 | — | 35.0 % | -20.1 % | -1,011.6 % | -1.6 % | — | — | +7.7 % | — | 0.0 % | 0.0 % | 0.3 | 68.6 % | 9.3 % | — |
| COCH Envoy Medical Inc. | 07/30 | -33 % | 93 9/22 | Stage 4 | D 27 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 0.67 $ | -1.7 % | -8.8 % | -54.0 % | −64.4 % | +273.1 % | 11 | 42 | 10.6 % | 7.5 % | 1.86 | — | 0.0 | 260.0 | — | — | — | -1.4 | — | -229.5 % | 0.0 % | 0.0 % | -71.3 % | — | — | +7.1 % | — | 0.0 % | 0.0 % | -32.6 | 22.9 % | 2.5 % | — |
| ULH Universal Logistics Holdings Inc | 07/23 | -15 % | 67 8/29 | Stage 4 | D 31 | 3 of 9 | 0.4 $ | Trucking | – | — | — | Industrials | 13.40 $ | -2.4 % | -2.8 % | -42.8 % | −50.5 % | +11.9 % | 10 | 6 | 6.3 % | 6.6 % | 0.69 | — | 11.2 | 0.2 | 0.7 | — | 3.73 | 15.1 | — | 19.1 % | -6.0 % | -18.5 % | 1.2 % | 1.73 | — | -15.6 % | — | 3.1 % | 1.6 % | 4.6 | 28.6 % | 12.7 % | 3.0 (1) |
| TELA Tela Bio Inc | 08/10 | -31 % | 94 9/22 | Stage 4 | D 35 | 4 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.73 $ | -33.4 % | -35.9 % | -57.1 % | −66.4 % | +204.1 % | 10 | 42 | 12.2 % | 11.7 % | 1.34 | — | 0.0 | 0.5 | 7.2 | — | — | -5.0 | — | 67.7 % | -49.3 % | -616.6 % | -28.7 % | -10.84 | — | +15.8 % | — | 0.0 % | 0.0 % | -14.8 | 69.0 % | 1.0 % | — |
| AVAV AeroVironment Inc | — | +21 % | 59 7/29 | Stage 4 | C 45 | 2 of 9 | 7.6 $ | Aerospace & Defense | – | — | — | Industrials | 149.40 $ | -38.4 % | -46.7 % | -44.2 % | −67.3 % | +51.1 % | 9 | 89 | 5.4 % | 6.4 % | 1.40 | — | 47.6 | 4.7 | 1.8 | — | 1.57 | 69.6 | -5.1 % | 25.3 % | -13.4 % | -8.7 % | -1.3 % | 0.46 | 77.0 % | +14.5 % | — | 0.0 % | 0.0 % | 8.5 | 89.2 % | 10.1 % | 4.4 (19) |
| CCLD CareCloud, Inc. | 08/04 | -21 % | 57 5/22 | Stage 4 | C 52 | 4 of 9 | 0.1 $ | Health Information Services | – | — | — | Healthcare | 2.40 $ | -24.3 % | -30.1 % | +2.5 % | −48.1 % | +194.5 % | 9 | 98 | 4.6 % | 4.9 % | 1.52 | 19.1 | 6.3 | 0.8 | 1.8 | 3.7 | 0.31 | 3.5 | — | 47.0 % | 7.9 % | 17.4 % | 8.1 % | 0.10 | — | +8.7 % | — | 0.0 % | 0.0 % | 4.4 | 28.8 % | 0.9 % | — |
| MCRB Seres Therapeutics Inc | 08/05 | -31 % | 57 5/22 | Stage 4 | D 28 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.80 $ | -52.6 % | -49.1 % | -66.1 % | −77.2 % | +148.5 % | 9 | 3 | 11.2 % | 9.5 % | 0.10 | — | 10.8 | 40.0 | — | — | — | 7.9 | — | -4,560.1 % | 0.0 % | -121.9 % | -38.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -25.9 | 24.4 % | 3.0 % | — |
| NTHI NeOnc Technologies Holdings, Inc. Common Stock | 08/17 | — | 97 10/22 | Stage 4 | E 20 | 3 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 3.50 $ | -41.0 % | -46.9 % | -28.8 % | −65.3 % | +254.8 % | 9 | 42 | 10.7 % | 9.8 % | — | — | 0.0 | — | 0.0 | — | — | 0.0 | — | — | 0.0 % | 0.0 % | -354.6 % | -0.03 | — | -51.8 % | — | 0.0 % | 0.0 % | -188.6 | 11.1 % | 2.5 % | — | |
| CRVO CervoMed Inc. | 08/14 | -28 % | 16 2/22 | Stage 4 | D 25 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | -52.9 % | -79.6 % | -68.7 % | −74.5 % | +482.1 % | 8 | 42 | 21.8 % | 12.8 % | -4.42 | — | 0.0 | 10.0 | 2.4 | — | — | 1.6 | — | -958.5 % | 0.0 % | -132.8 % | -72.4 % | — | — | -58.9 % | — | 0.0 % | 0.0 % | -18.8 | 13.3 % | 5.4 % | — |
| PETS PetMed Express Inc | — | -29 % | 42 4/22 | Stage 4 | E 21 | 3 of 9 | 0.0 $ | Pharmaceutical Retailers | – | — | — | Healthcare | 2.00 $ | -42.8 % | -48.7 % | -37.5 % | −56.8 % | +21.5 % | 8 | 92 | 6.3 % | 5.9 % | 0.78 | — | 16.7 | 0.2 | — | — | 2.32 | 3.5 | — | 28.1 % | -32.0 % | -100.4 % | -15.4 % | — | — | -34.7 % | — | 0.0 % | 0.0 % | 1.5 | 44.8 % | 3.9 % | — |
| RMTI Rockwell Medical Inc | 08/13 | -28 % | 58 5/22 | Stage 4 | D 26 | 4 of 9 | 0.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 7.20 $ | -19.9 % | -27.4 % | -22.7 % | −69.0 % | +4,515.4 % | 8 | 42 | 6.4 % | 5.9 % | 1.62 | — | 33.0 | 0.5 | 0.8 | 18.3 | 4.43 | 22.1 | — | 17.1 % | -8.0 % | -16.0 % | -5.4 % | 0.40 | — | -31.8 % | — | 0.0 % | 0.0 % | -15.4 | 10.1 % | 1.9 % | — |
| SKYE Skye Bioscience, Inc. | 08/06 | -29 % | 58 5/22 | Stage 4 | E 18 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.57 $ | -6.7 % | -19.6 % | -84.1 % | −87.7 % | +986.5 % | 8 | 42 | 7.9 % | 8.1 % | 2.94 | — | 0.0 | — | — | — | — | -2.6 | — | — | 0.0 % | -168.0 % | -87.7 % | — | — | +1,992.8 % | — | 0.0 % | 0.0 % | -46.4 | 46.0 % | 3.9 % | — |
| FEAM 5E Advanced Materials Inc | — | -33 % | 38 4/23 | Stage 4 | D 33 | 4 of 9 | 0.0 $ | Specialty Chemicals | – | — | — | Basic Materials | 1.10 $ | -50.8 % | -59.3 % | -69.8 % | −82.5 % | +262.6 % | 7 | 42 | 8.4 % | 8.8 % | 1.90 | — | 0.0 | 6.2 | 0.7 | — | — | -2.9 | — | -16,642.5 % | 0.0 % | -62.4 % | -34.6 % | 0.00 | — | -100.0 % | — | 0.0 % | 0.0 % | 5.4 | 69.6 % | 0.6 % | — |
| SOC Sable Offshore Corp. | 08/11 | -4 % | 80 3/10 | Stage 1 | D 29 | 3 of 9 | 0.9 $ | Oil & Gas Drilling | – | — | — | Energy | 5.30 $ | -0.9 % | -29.3 % | -82.8 % | −76.4 % | +151.6 % | 5 | 42 | 8.8 % | 9.1 % | -0.08 | — | 109.9 | 661.5 | 1.9 | — | — | -130.8 | — | -19,788.9 % | 0.0 % | -141.7 % | -17.4 % | 2.27 | — | — | — | 0.0 % | 0.0 % | -4.2 | 92.6 % | 30.1 % | 4.8 (5) |
| HUMA Humacyte Inc | 08/10 | -26 % | 16 2/22 | Stage 4 | D 34 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 0.65 $ | -27.1 % | -26.0 % | -72.8 % | −78.2 % | +230.6 % | 5 | 42 | 14.9 % | 12.7 % | 2.52 | — | 35.8 | 84.3 | 17.0 | — | — | 4.3 | — | -4,053.7 % | 0.0 % | -409.5 % | -51.5 % | 5.67 | — | -100.0 % | — | 0.0 % | 0.0 % | -21.1 | 22.3 % | 13.7 % | — |
| BYND Beyond Meat Inc | 08/05 | -33 % | 28 2/16 | Stage 4 | D 26 | 4 of 9 | 0.3 $ | Packaged Foods | – | — | — | Consumer Defensive | 0.57 $ | -17.3 % | -28.2 % | -81.4 % | −91.1 % | +2.9 % | 5 | 42 | 6.9 % | 6.9 % | 2.75 | — | 5,000.0 | 1.1 | 49.4 | — | 40.75 | 2.2 | — | 10.8 % | 95.0 % | -1,167.0 % | -17.0 % | -23.58 | — | -15.6 % | — | 0.0 % | 0.0 % | -4.6 | 38.1 % | 28.9 % | — |
| CRDF Cardiff Oncology Inc | 08/04 | -5 % | 16 2/22 | Stage 4 | E 21 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.86 $ | -55.5 % | -60.1 % | -63.7 % | −73.5 % | +330.9 % | 5 | 42 | 10.3 % | 10.0 % | 1.44 | — | 0.0 | 155.0 | 1.7 | — | — | -3.7 | — | -5,922.3 % | 0.0 % | -84.8 % | -44.3 % | 0.02 | — | -13.2 % | — | 0.0 % | 0.0 % | -25.3 | 32.8 % | 24.2 % | — |
| INO Inovio Pharmaceuticals Inc | 08/11 | -26 % | 57 5/22 | Stage 4 | D 34 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.68 $ | -35.1 % | -50.2 % | -52.1 % | −63.8 % | +439.4 % | 5 | 42 | 4.8 % | 6.5 % | 1.49 | — | 16.6 | — | 9.3 | — | — | -1.1 | — | — | 0.0 % | -296.4 % | -76.4 % | 1.43 | — | -70.0 % | — | 0.0 % | 0.0 % | -128.0 | 47.3 % | 22.5 % | — |
| NXXT NextNRG Inc. | 08/13 | -32 % | 71 4/15 | Stage 4 | C 47 | 3 of 9 | 0.1 $ | Utilities - Renewable | – | — | — | Utilities | 0.27 $ | -70.3 % | -91.2 % | -79.6 % | −87.3 % | +1,150.0 % | 5 | 42 | 17.1 % | 20.7 % | 0.03 | 0.3 | 0.0 | 0.6 | 0.0 | — | — | 0.0 | — | 9.4 % | -101.2 % | 0.0 % | -215.5 % | -1.31 | — | +194.7 % | — | 0.0 % | 0.0 % | -83.3 | 6.3 % | 7.1 % | — |
| SRFM Surf Air Mobility Inc. | 08/11 | — | 9 2/29 | Stage 4 | D 32 | 4 of 9 | 0.1 $ | Airlines | – | — | — | Industrials | 0.76 $ | -45.9 % | -56.3 % | -81.7 % | −90.8 % | +483.8 % | 5 | 42 | 12.5 % | 9.2 % | 2.76 | — | 0.0 | 0.7 | 2.0 | — | — | -0.6 | — | 4.7 % | -103.4 % | 0.0 % | -39.6 % | -1.60 | — | -10.8 % | — | 0.0 % | 0.0 % | -29.5 | 19.1 % | 14.5 % | — |
| MVST Microvast Holdings Inc | 08/10 | -27 % | 33 5/31 | Stage 4 | D 41 | 3 of 9 | 0.3 $ | Auto Parts | – | — | — | Consumer Cyclical | 0.81 $ | -54.6 % | -62.5 % | -74.5 % | −84.2 % | +386.7 % | 4 | 88 | 9.0 % | 8.7 % | 3.49 | — | 6.2 | 0.7 | — | 8.4 | — | 271.7 | — | 35.2 % | -11.5 % | -9.3 % | 1.2 % | — | — | +12.6 % | — | 0.0 % | 0.0 % | 0.2 | 25.3 % | 12.7 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The working version of our own analysis of 792 U.S. bankruptcies since 2005. Its core finding: no single warning sign carries a verdict — even the sharpest one is wrong in more than 95 out of 100 cases. Only accumulation matters. With no signal active, 0.18 percent of companies filed for bankruptcy within twelve months; with six active at once, 3.16 percent did.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 122 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.